These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of nonachlazine on the echocardiographic parameters in patients with post-infarct cardiosclerosis]. Iagus KhK. Ter Arkh; 1980; 52(5):42-6. PubMed ID: 7404363 [No Abstract] [Full Text] [Related]
4. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients]. Zaslavskaia RM, Zolotaia RD, Olevskiĭ IKh, Duda SG, Vilkovyskiĭ FA. Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152 [Abstract] [Full Text] [Related]
16. [Mechanisms of the inotropic action of nonachlazine]. Kaverina NV, Katsenovich RA, Tkachenko BI, Iunusov ZZ, Ovsiannikov VI. Farmakol Toksikol; 1985 Jan; 48(1):23-7. PubMed ID: 3979531 [Abstract] [Full Text] [Related]
17. [Effect of nonachlazine on the energy provision for cardiac contractile activity in experimental myocardial infarct]. Reznikov KM, Provotorova PP, Sidel'nikova VI. Farmakol Toksikol; 1982 Jan; 45(5):52-7. PubMed ID: 7140956 [Abstract] [Full Text] [Related]
18. [Use of computers for detecting the dynamics of changes in the cardiac adaptation reserves of alcoholism patients treated with nonachlazine]. Kaverina NV, Berdiaev SIu, Mel'nikova TS. Biull Eksp Biol Med; 1982 May; 93(5):68-72. PubMed ID: 7046840 [Abstract] [Full Text] [Related]
19. [Anti-inflammatory action of nonachlazine, a new circulatory drug]. Krupińska J, Kawierina NW, Cebo B. Folia Med Cracov; 1981 May; 23(2):289-95. PubMed ID: 7047323 [No Abstract] [Full Text] [Related]
20. [Pharmacological and clinical study of the liquid drug form of nonachlazine]. Kniazev MD, Kaverina NV, Aslibekian IS, Kirichenko AA, Vorovkov AI. Kardiologiia; 1979 Oct; 19(10):14-7. PubMed ID: 502162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]